{"id":"tp-52982","type":"article-newspaper","title":"Heron Therapeutics Q3 Net Revenue Falls 7.8% as Net Loss Narrows","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/52982","datePublished":"2026-11-10T09:59:56.000Z","dateModified":"2026-11-10T09:59:56.000Z","language":"en","abstract":"Net loss declined to $5 million from $17.5 million a year earlier. CorMedix Therapeutics agreed to acquire substantially all of Heron's assets.","section":"Business","references":[{"title":"previously scheduled earnings call","url":"https://www.tokenpost.com/news/business/51673"}]}